US$ 28.30
case report aspiration during anesthesia glp-1 receptor agonist 2023 Glucagon-Like Peptide-1 Agonists Do Not Increase Upper Endoscopy in Patients With Diabetes Perioperative management of patients taking
Description
It is typically prescribed when other glucose-lowering therapies, such as metformin, have not achieved adequate glycaemic control

Tolerability: Can your GI tract handle the common side effects associated with these medications

Researchers testing the medications on mice found no significant effects of the drug

Gastroparesis with bezoar formation in patients treated with glucagon-like peptide-1 receptor agonists: potential relevance for bariatric and other gastric surgery

Chronic hyperglycemia in diabetes downregulates GIP receptor (GIPR) expression and impairs GIP-mediated insulin secretion [21], rendering high-doses of GIP infusions ineffective [22]

10.2337/db13-0805 189 VillhauerE
